Abstract
dc:descriptionObesity is a multifactorial disease that the genetic factor in relation to the environment can be responsible for up to 70% of body weight’s variability. The bariatric surgery is the most effective treatment for severe obesity compared to other approaches, such as diet modification, increased physical activity and pharmacological interventions. But there is a high inter-subject variability for weight loss after a bariatric surgery. The aim of this prospective study was to examine the association of a Genetic Risk Score (GRS) with excess weight loss after gastric Roux-en-Y bypass or sleeve gastrectomy. A total of forty-seven patients with morbid obesity of Greek origin undergone sleeve gastrectomy (81%) or gastric bypass were included in the study. These individuals were genotyped and we monitored their post-operative weight loss, up to two years after surgery. In addition, visceral and subcutaneous adipose tissue were sampled in a subset of these patients, as well as in subjects with normal BMI and RNA sequencing was performed. Gene expression levels were compared between the two types of adipose tissue.Weight loss after surgery was reported as the percentage of excess weight lost (% EWL) at 12 (EWL12) and 24 (EWL24) months after surgery. A Genetic Risk Score (GRS) was constructed from previously reported single nucleotide polymorphisms (SNPs) related to BMI and waist-to-hip circumference (WHR). The level of weight loss after 12 and 24 months post-surgery surgery was assessed through two multiple linear regression models. The first proposed model suggested that the variables Genetic Risk Score, Age and BMI had a significant effect on EWL12. GRS was significantly associated with EWL12, indicating a decrease of 4.618% per score unit. The second model indicated a positive correlation between EWL24 and EWL12. GRS was also significantly associated with EWL24, indicating approximately 3% decrease of EWL24 per score unit. Top differentially expressed genes between visceral and subcutaneous adipose tissue included genes involved in developmental processes in subcutaneous tissue and genes involved in the immune response and glucose uptake in the visceral adipose tissue respectively. GRS can be used in the future together with other preoperative parameters in order to predict the outcome of bariatric surgery and allow for personalization of treatment of morbid obesity.
Degree
thesis:*- Grantor dc:publisher
- Harokopio University
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsareli, Efthymia
- Κατσαρέλη, Ευθυμία
Subjects
dc:subject × 14Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47254